1,228
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Omentin-1 ameliorates pulmonary arterial hypertension by inhibiting endoplasmic reticulum stress through AMPKα signaling

, , , &
Article: 2332695 | Received 01 Feb 2024, Accepted 14 Mar 2024, Published online: 25 Mar 2024

References

  • Ruopp NF, Cockrill BA. Diagnosis and treatment of pulmonary arterial hypertension: a review. JAMA. 2022;327(14):1379–8. doi:10.1001/jama.2022.4402.
  • Beshay S, Sahay S, Humbert M. Evaluation and management of pulmonary arterial hypertension. Respir Med. 2020;171:106099. doi:10.1016/j.rmed.2020.106099.
  • Ghofrani HA, Voswinckel R, Reichenberger F, Weissmann N, Schermuly RT, Seeger W, Grimminger F. Hypoxia- and non-hypoxia-related pulmonary hypertension — established and new therapies. Cardiovasc Res. 2006;72(1):30–40. doi:10.1016/j.cardiores.2006.07.025.
  • Naeije R, Richter MJ, Rubin LJ. The physiological basis of pulmonary arterial hypertension. Eur Respir J. 2022;59(6):2102334. doi:10.1183/13993003.02334-2021.
  • Lan C, Fang G, Qiu C, Li X, Yang F, Yang Y. Inhibition of DYRK1A attenuates vascular remodeling in pulmonary arterial hypertension via suppressing STAT3/Pim-1/NFAT pathway. Clin Exp Hypertens. 2024;46:2297642. doi:10.1080/10641963.2023.2297642.
  • Gorelova A, Berman M, Al Ghouleh I. Endothelial-to-mesenchymal transition in pulmonary arterial hypertension. Antioxid Redox Signal. 2021;34:891–914. doi:10.1089/ars.2020.8169.
  • Klinger JR, Abman SH, Gladwin MT. Nitric oxide deficiency and endothelial dysfunction in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2013;188(6):639–46. doi:10.1164/rccm.201304-0686PP.
  • Bhogal S, Khraisha O, Al Madani M, Treece J, Baumrucker SJ, Paul TK. Sildenafil for pulmonary arterial hypertension. Am J Ther. 2019;26(4):e520–26. doi:10.1097/MJT.0000000000000766.
  • Askin L, Duman H, Ozyildiz A, Tanriverdi O, Turkmen S. Association between omentin-1 and coronary artery disease: pathogenesis and clinical research. Curr Cardiol Rev. 2020;16(3):198–201. doi:10.2174/1573403X16666200511085304.
  • Sun Y, Jiang R, Hu X, Gong S, Wang L, Wu W, Li J, Kang X, Xia S, Liu J, et al. CircGSAP alleviates pulmonary microvascular endothelial cells dysfunction in pulmonary hypertension via regulating miR-27a-3p/BMPR2 axis. Respir Res. 2022;23(1):322. doi:10.1186/s12931-022-02248-7.
  • Abe JI, Ko KA, Kotla S, Wang Y, Paez-Mayorga J, Shin IJ, Imanishi M, Vu HT, Tao Y, Leiva-Juarez MM, et al. MAGI1 as a link between endothelial activation and ER stress drives atherosclerosis. JCI Insight. 2019;4(7). doi:10.1172/jci.insight.125570.
  • Pan T, Zhang L, Miao K, Wang Y. A crucial role of endoplasmic reticulum stress in cellular responses during pulmonary arterial hypertension. Am J Transl Res. 2020;12(5):1481–90.
  • Zhuan B, Wang X, Wang MD, Li ZC, Yuan Q, Xie J, Yang Z. Hypoxia induces pulmonary artery smooth muscle dysfunction through mitochondrial fragmentation-mediated endoplasmic reticulum stress. Aging (Albany NY). 2020;12(23):23684–97. doi:10.18632/aging.103892.
  • Luo H, Lan C, Fan C, Gong X, Chen C, Yu C, Wang J, Luo X, Hu C, Jose PA, et al. Down-regulation of AMPK/PPARδ signalling promotes endoplasmic reticulum stress-induced endothelial dysfunction in adult rat offspring exposed to maternal diabetes. Cardiovasc Res. 2022;118(10):2304–16. doi:10.1093/cvr/cvab280.
  • Correale M, Tricarico L, Grazioli D, Formica ES, Petrucci R, Persichella P, Di Biase M, Brunetti ND. Drug-induced pulmonary arterial hypertension: mechanisms and clinical management. Cardiovasc Drugs Ther. 2019;33(6):725–38. doi:10.1007/s10557-019-06920-x.
  • Evans CE, Cober ND, Dai Z, Stewart DJ, Zhao YY. Endothelial cells in the pathogenesis of pulmonary arterial hypertension. Eur Respir J. 2021;58(3):58. doi:10.1183/13993003.03957-2020.
  • Watanabe T, Watanabe-Kominato K, Takahashi Y, Kojima M, Watanabe R. Adipose tissue-derived omentin-1 function and regulation. Compr Physiol. 2017;7:765–81. doi:10.1002/cphy.c160043.
  • Zhao A, Xiao H, Zhu Y, Liu S, Zhang S, Yang Z, Du L, Li X, Niu X, Wang C, et al. Omentin-1: a newly discovered warrior against metabolic related diseases. Expert Opin Ther Targets. 2022;26(3):275–89. doi:10.1080/14728222.2022.2037556.
  • Celik M, Nar R, Nar G, Sokmen E, Gunver G. Serum omentin-1 levels in hypertensive patients. J Hum Hypertens. 2021;35(3):290–95. doi:10.1038/s41371-020-00420-4.
  • Biscetti F, Nardella E, Bonadia N, Angelini F, Pitocco D, Santoliquido A, Filipponi M, Landolfi R, Flex A. Association between plasma omentin-1 levels in type 2 diabetic patients and peripheral artery disease. Cardiovasc Diabetol. 2019;18(1):74. doi:10.1186/s12933-019-0880-7.
  • Biscetti F, Nardella E, Rando MM, Cecchini AL, Angelini F, Cina A, Iezzi R, Filipponi M, Santoliquido A, Pitocco D, et al. Association between omentin-1 and major cardiovascular events after lower extremity endovascular revascularization in diabetic patients: a prospective cohort study. Cardiovasc Diabetol. 2020;19(1):170. doi:10.1186/s12933-020-01151-z.
  • Elsaid NH, Sadik NA, Ahmed NR, Fayez SE, Mohammed NAE. Serum omentin-1 levels in type 2 diabetic obese women in relation to glycemic control, insulin resistance and metabolic parameters. J Clin Transl Endocrinol. 2018;13:14–19. doi:10.1016/j.jcte.2018.05.003.
  • Xiang Y, Zhou Z, Zhu L, Li C, Luo Y, Zhou J. Omentin-1 enhances the inhibitory effect of endothelial progenitor cells on neointimal hyperplasia by inhibiting the p38 MAPK/CREB pathway. Life Sci. 2023;331:122061. doi:10.1016/j.lfs.2023.122061.
  • Uemura Y, Shibata R, Kanemura N, Ohashi K, Kambara T, Hiramatsu-Ito M, Enomoto T, Yuasa D, Joki Y, Matsuo K, Ito, M., et al. Adipose-derived protein omentin prevents neointimal formation after arterial injury. FASEB J. 2015;29(1):141–151. 10.1096/fj.14-258129
  • Liu F, Fang S, Liu X, Li J, Wang X, Cui J, Chen T, Li Z, Yang F, Tian J, et al. Omentin-1 protects against high glucose-induced endothelial dysfunction via the AMPK/PPARδ signaling pathway. Biochem Pharmacol. 2020;174:113830.
  • Zhu J, Shao A, Wang C, Zeng C, Wang H. Inhibition of endoplasmic reticulum stress restores the balance of renal RAS components and lowers blood pressure in the spontaneously hypertensive rats. Clin Exp Hypertens. 2023;45:2202367. doi:10.1080/10641963.2023.2202367.
  • Ozcan L, Tabas I. Calcium signalling and ER stress in insulin resistance and atherosclerosis. J Intern Med. 2016;280(5):457–64. doi:10.1111/joim.12562.
  • Katseff A, Alhawaj R, Wolin MS. Redox and inflammatory signaling, the unfolded protein response, and the pathogenesis of pulmonary hypertension. Adv Exp Med Biol. 2021;1304:333–73. doi:10.1007/978-3-030-68748-9_17.
  • Zachariah M, Maamoun H, Milano L, Rayman MP, Meira LB, Agouni A. Endoplasmic reticulum stress and oxidative stress drive endothelial dysfunction induced by high selenium. J Cell Physiol. 2021;236:4348–59. doi:10.1002/jcp.30175.
  • Liu H, Li Y, Li M, Xie L, Li F, Pan R, Pei F. Follistatin-like 1 protects endothelial function in the spontaneously hypertensive rat by inhibition of endoplasmic reticulum stress through AMPK-dependent mechanism. Clin Exp Hypertens. 2023;45(1):2277654. doi:10.1080/10641963.2023.2277654.
  • Koyama M, Furuhashi M, Ishimura S, Mita T, Fuseya T, Okazaki Y, Yoshida H, Tsuchihashi K, Miura T. Reduction of endoplasmic reticulum stress by 4-phenylbutyric acid prevents the development of hypoxia-induced pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol. 2014;306(9):H1314–23. doi:10.1152/ajpheart.00869.2013.
  • Lenna S, Townsend DM, Tan FK, Kapanadze B, Markiewicz M, Trojanowska M, Scorza R. HLA-B35 upregulates endothelin-1 and downregulates endothelial nitric oxide synthase via endoplasmic reticulum stress response in endothelial cells. J Immunol. 2010;184(9):4654–61. doi:10.4049/jimmunol.0903188.
  • Wu S, Zou MH. AMPK, Mitochondrial function, and cardiovascular disease. IJMS. 2020;21(14):4987. doi:10.3390/ijms21144987.
  • Moral-Sanz J, Lewis SA, MacMillan S, Meloni M, McClafferty H, Viollet B, Foretz M, Del-Pozo J, Mark Evans A. AMPK deficiency in smooth muscles causes persistent pulmonary hypertension of the new-born and premature death. Nat Commun. 2022;13(1):5034. doi:10.1038/s41467-022-32568-7.
  • Zhang Q, Li W, Zhu Y, Wang Q, Zhai C, Shi W, Feng W, Wang J, Yan X, Chai L, et al. Activation of AMPK inhibits galectin-3-induced pulmonary artery smooth muscle cells proliferation by upregulating hippo signaling effector YAP. Mol Cell Biochem. 2021;476(8):3037–49. doi:10.1007/s11010-021-04131-3.
  • Yao W, Wang K, Wang X, Li X, Dong J, Zhang Y, Ding X. Icariin ameliorates endothelial dysfunction in type 1 diabetic rats by suppressing ER stress via the PPARα/Sirt1/AMPKα pathway. J Cell Physiol. 2021;236(3):1889–902. doi:10.1002/jcp.29972.